期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 276, 期 1-2, 页码 195-201出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2014.08.623
关键词
Progressive multiple sclerosis; Methylprednisolone; CCR2; CD38; CD80; CD70; CD27
Objective: To investigate the effect of monthly oral methylprednisolone pulse treatment in progressive MS. Methods: 30 progressive MS patients were treated with oral methylprednisolone every month. Peripheral blood mononuclear cells were analyzed by flow cytometry. Results: Out of 102 leukocyte phenotypes investigated, 25 changed at nominal significance from baseline to week 12 (p < 0.05). After correction for multiple comparisons, we found 5 subpopulations that changed compared to baseline. No pattern were suggesting modulation of Th17 or TFH cells. Conclusion: Methylprednisolone pulse treatment has some effects on circulating immune cells but does not modulate markers of Th17 and TFH cell activity in progressive MS. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据